18,618 followers
A first-in-human phase 1 study of cavrotolimod, a TLR9 agonist spherical nucleic acid, in healthy participants: Evidence of immune activation https://t.co/vS0kRUYPN3 https://t.co/bITsd7p0Nb
A first-in-human phase 1 study of cavrotolimod, a TLR9 agonist spherical nucleic acid, in healthy participants: Evidence of immune activation https://t.co/vS0kRUYPN3 https://t.co/bITsd7p0Nb
RT @FrontImmunol: New Research: A first-in-human phase 1 study of cavrotolimod, a TLR9 agonist spherical nucleic acid, in healthy participa…
New Research: A first-in-human phase 1 study of cavrotolimod, a TLR9 agonist spherical nucleic acid, in healthy participants: Evidence of immune activation: Introduction Tumor immunotherapy is designed to control malignancies through the… https://t.co/JvI